Co-Diagnostics

$1.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (2.83%) Today
-$0.02 (-1.83%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Co-Diagnostics and other stocks, options, ETFs, and crypto commission-free!

About CODX

Co-Diagnostics, Inc. Common Stock, also called Co-Diagnostics, is a molecular diagnostics company, which engages in the development, manufacture, and marketing of diagnostics technology. Read More The company's products are utilized for tests that are designed using the detection and analysis of nucleic acid molecules. It also uses its proprietary technology to design tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Employees
20
Headquarters
Salt Lake City, Utah
Founded
2013
Market Cap
18.66M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
174.29K
High Today
$1.09
Low Today
$1.05
Open Price
$1.05
Volume
56.86K
52 Week High
$3.77
52 Week Low
$0.694

Collections

CODX Earnings

-$0.13
-$0.11
-$0.10
-$0.08
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 13, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.